In this study, we uncovered that well-known TFs, FOXA1 and GRHL2 are key epigenetic regulators distinguishing the diversity of genome-wide chromatin accessibility pattern across breast cancer cell lines. This evidence concerns the gene GRHL2 and breast carcinoma.